Last $1.50 USD
Change Today -0.07 / -4.46%
Volume 2.4M
AMRN On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

amarin corporation plc -adr (AMRN) Snapshot

Open
$1.55
Previous Close
$1.57
Day High
$1.58
Day Low
$1.49
52 Week High
09/6/13 - $7.40
52 Week Low
05/21/14 - $1.28
Market Cap
258.7M
Average Volume 10 Days
1.3M
EPS TTM
$-1.03
Shares Outstanding
172.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AMARIN CORPORATION PLC -ADR (AMRN)

amarin corporation plc -adr (AMRN) Related Businessweek News

No Related Businessweek News Found

amarin corporation plc -adr (AMRN) Details

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases in the United States. It develops products in the areas of lipid science and therapeutic benefits of polyunsaturated fatty acids. The company markets Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It is also developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.

185 Employees
Last Reported Date: 02/27/14
Founded in 1989

amarin corporation plc -adr (AMRN) Top Compensated Officers

Chief Executive Officer, President, Assistant...
Total Annual Compensation: $395.2K
Senior Vice President and President of Resear...
Total Annual Compensation: $384.3K
Head of Development and Senior Vice President
Total Annual Compensation: $360.5K
Chief Compliance Officer, Senior Vice Preside...
Total Annual Compensation: $358.0K
Compensation as of Fiscal Year 2013.

amarin corporation plc -adr (AMRN) Key Developments

Amarin Corporation plc Appoints Ernst & Young LLP as Independent Registered Public Accounting Firm for 2014

Amarin Corporation plc announced in it's annual general meeting of shareholders held on July 7, 2014, the share holders ratify the audit committee’s appointment of Ernst & Young LLP as the company’s U.S. independent registered public accounting firm for 2014 and U.K. statutory auditors under Companies Act 2006 to hold office until the conclusion of the next annual general meeting.

Amarin Corporation plc Presents at Goldman Sachs 35th Annual Global Healthcare Conference, Jun-11-2014 03:20 PM

Amarin Corporation plc Presents at Goldman Sachs 35th Annual Global Healthcare Conference, Jun-11-2014 03:20 PM. Venue: Terranea Resort in Rancho Palos Verdes, 100 Terranea Way, Los Angeles, California, United States. Speakers: John F. Thero, Chief Executive Officer, President, Assistant Secretary and Director.

Amarin Corporation plc Presents at Jefferies 2014 Global Healthcare Conference, Jun-05-2014 08:00 AM

Amarin Corporation plc Presents at Jefferies 2014 Global Healthcare Conference, Jun-05-2014 08:00 AM. Venue: Grand Hyatt, New York, New York, United States. Speakers: John F. Thero, Chief Executive Officer, President, Assistant Secretary and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMRN:US $1.50 USD -0.07

AMRN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AMRN.
View Industry Companies
 

Industry Analysis

AMRN

Industry Average

Valuation AMRN Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMARIN CORPORATION PLC -ADR, please visit www.amarincorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.